The primary objective is to evaluate the efficacy of the treatment with supplementary oxygen added to conventional anticoagulant treatment in patients with Intermediate-risk pulmonary embolism. The secondary objective is to evaluate the safety of the treatment with supplementary oxygen added to conventional anticoagulant treatment in patients with Intermediate-risk pulmonary embolism.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
70
Supplementary oxygen during the first 48 hours added to conventional anticoagulant treatment. Patients will receive anticoagulant treatment according to updated guidelines.
Hospital Universitario Araba
Vitoria-Gasteiz, Alava, Spain
Hospital Galdakao-Usansolo
Galdakao, Vizcaya, Spain
Hospital Clínic de Barcelona
Barcelona, Spain
Clínica Universidad de Navarra
Madrid, Spain
Normal right ventricle function at 48 hours
Right ventricle (RV) to left ventricle (LV) diameter ratio equal or less than 1.0 measured 48 hours after initiation of therapy in normotensive patients with intermediate-risk pulmonary embolism (PE).
Time frame: 48 hours
Modification RV -LV 7 days
Modification of the right ventricle (RV) to the left ventricle (LV) diameter ratio measured 7 days after initiation of therapy in normotensive patients with intermediate-risk pulmonary embolism (PE).
Time frame: 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hospital Universitario Ramón y Cajal
Madrid, Spain
Hospital Universitario Virgen del Rocío
Seville, Spain
Hospital Universitario y Politécnico La Fe
Valencia, Spain